Key Takeaways:
A Cook County jury ordered Abbott Laboratories to pay $53 million in damages, finding the company failed to warn that its formula for premature infants could cause a potentially fatal bowel disease.
The verdict was reported Thursday by the Chicago Tribune, culminating a trial centered on claims from four mothers whose infants developed necrotizing enterocolitis (NEC) after using Abbott's product. The lawsuit alleged Abbott knew or should have known about the risks.
The $53 million award is for compensatory damages in a case that consolidates claims from four separate families. This case is one of thousands of similar lawsuits filed against Abbott and other formula manufacturers in the U.S. over the link between cow's milk-based formulas and NEC in preterm infants.
The verdict represents a significant legal setback for Abbott and highlights a growing liability risk for the infant nutrition industry. Rival Mead Johnson, owned by Reckitt Benckiser, was hit with a $60 million verdict in a similar Illinois case in March 2024, according to a report from Just Food. Both companies are facing numerous state and federal trials concerning the allegations.
The ongoing litigation poses a material risk to Abbott's nutrition segment, potentially leading to further substantial penalties and pressuring the company's market share in the sensitive infant formula sector. Investors will be closely watching the outcomes of pending federal and state trials scheduled for later this year to gauge the full extent of the financial exposure.
This article is for informational purposes only and does not constitute investment advice.
